Skip to main content
. 2014 Jan 7;99(3):1027–1036. doi: 10.1210/jc.2013-3399

Table 1.

Clinical, Biochemical, and Metabolic Characteristics in the Overall PCOS Cohort (n = 86), PCOS Androgen Phenotype Subgroups, and Age- and BMI-Matched Controls (n = 43)

Variable Controls (n = 43) All PCOS (n = 86) NA/NT (n = 10) HA/NT (n = 20) HA/HT (n = 56)
Age, y 32.4 ± 9.8 30.0 ± 7.2 32.9 ± 2.9 30.8 ± 7.9 28.8 ± 7.0
BMI, kg/m2 30.3 ± 6.4 31.9 ± 7.1 30.2 ± 6.5 30.0 ± 5.9 32.1 ± 6.5
Ferriman-Gallwey score 2.1 ± 1.6 12.4 ± 6.7a 9.9 ± 5.3a 10.1 ± 6.4a 13.9 ± 7.2a,b
T, nmol/L 1.3 ± 0.4 2.2 ± 0.8a 1.2 ± 0.3 1.6 ± 0.4 2.6 ± 0.7a,b
FAI (T × 100/SHBG) 3.2 ± 1.8 9.1 ± 6.1a 5.5 ± 3.9d 7.3 ± 4.6d 10.5 ± 6.5a,b
SHBG, nmol/L 49.8 ± 26.6 32.3 ± 18.4a 28.8 ± 11.8a 30.8 ± 21.2a 31.8 ± 16.5a
A, nmol/L 3.5 ± 1.4 13.4 ± 5.6a 5.1 ± 1.7 11.4 ± 4.2a,c 14.2 ± 5.1a,c
DHEA, nmol/L 20.5 ± 7.9 57.5 ± 30.0a 24.4 ± 8.6 59.8 ± 34.8a,e 58.0 ± 26.8a,e
DHEAS, μmol/L 3.9 ± 2.0 6.2 ± 3.0a 2.4 ± 1.2 6.3 ± 2.6c 6.2 ± 2.7a,c
DHEA to DHEAS ratio 7.8 ± 3.7 12.9 ± 6.8d 12.6 ± 8.5d 14.0 ± 10.0d 15.4 ± 5.4d
LH, IU/L 5.2 ± 2.4 9.9 ± 5.8d 4.7 ± 3.2 9.0 ± 6.3d 11.4 ± 9.2b,d
LH to FSH ratio 0.8 ± 0.5 2.0 ± 1.5d 0.9 ± 0.7 2.1 ± 1.9d 2.3 ± 1.4b,d
Fasting glucose, mmol/L 4.6 ± 0.5 4.8 ± 0.7 5.0 ± 0.5 4.7 ± 0.5 4.8 ± 0.8
Two-hour OGTT glucose, mmol/L 6.7 ± 1.5 6.5 ± 2.2 5.5 ± 1.2 6.7 ± 1.9 6.7 ± 2.3
Fasting insulin, mIU/L 2.0 ± 1.5 10.4 ± 8.6f 8.2 ± 5.5d 11.7 ± 8.3d 12.3 ± 6.6a
HOMA-IR 0.9 ± 0.8 2.3 ± 0.2f 1.9 ± 1.1d 2.4 ± 1.5d 2.8 ± 1.0b,f
ISI (Cederholm), mg/L2/mmol · mU · min) (25) 78.7 ± 38.0 54.6 ± 24.1a 73.4 ± 54.6 51.0 ± 17.1a,f 54.4 ± 25.2a,f
Dysglycemia, n, % 3 (6.9%) 17 (19.7%)d 0 3 (15%) 14 (25%)b,d

Abbreviation: HOMA-IS, homeostatic model assessment of insulin sensitivity. PCOS subgroup classification according to high (H) or normal (N) serum A and serum T concentrations as measured by LC/MS-MS [normal T (NT) ≤1.9 nmol/L; normal A (NA) ≤7.4 nmol/L]. Data are expressed as mean ± SD unless otherwise stated. Normal glucose tolerance was a 2-hour glucose OGTT 7.7 mmol/L or less. Dysglycemia was a 2-h glucose OGTT 7.8 mmol/L or greater.

a

P < .001 as compared with the BMI-matched healthy controls

b

P < .05 as compared with the NA/NT group.

c

P < .001 as compared with the NA/NT group.

d

P < .05 as compared with the BMI-matched healthy controls.

e

P < .01 as compared with the NA/NT group.

f

P < .01 as compared with the BMI-matched healthy controls.